Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (96757)	1/25/2005 4:04:09 PM
From: Lane3	Read Replies (1) \| Respond to of 793716

I'd like to cut-and-paste part of the article, but I left my mouse at the office and can't figure out how to cut-and-paste using a touchpad (with buttons). My touchpad works just like a mouse. Hold down the left button while dragging on the pad to select. Right click to get the copy and paste options. I'm failing to recognize the problem, I guess. I remember once giving you a long explanation of how to get your SI window narrower that I assume was just as unintentionaly insulting, given that you never thanked me for it... <g> Even the developers of BiDil admit that race is too crude of a way of getting at genetic variations, but they've been able to sell the patent office on the use of race as a way of extending their patents. As long as the drug is effective as promised, I don't see the problem. I take Nexium. To me that seemed like a pretty contorted way to extend a patent. I assume that doctors can prescribe Bi and Dil separately if it costs less that way.